Markers of metastatic colorectal cancer

Piotr Myśliwiec; Barbara Choromanska; Jacek Dadan

doi:10.5114/pg.2019.84848

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2020
vol. 15

Send email

Copy url:

abstract:

Review paper

Markers of metastatic colorectal cancer

Piotr Myśliwiec

¹

,

Barbara Choromanska

¹

,

Jacek Dadan

¹

1st Department of General and Endocrinological Surgery, Medical University of Bialystok, Bialystok, Poland

Gastroenterology Rev 2020; 15 (2): 94–97

DOI: https://doi.org/10.5114/pg.2019.84848

Online publish date: 2019/05/08

View full text Get citation

PlumX metrics:

Metastatic colorectal cancer (CRC) is a major cause of cancer-related death. However, early diagnosis of CRC metastases offers a chance of long-term survival in as much as 40% of patients after curative treatment. Current guidelines are based on clinical examination, carcinoembryonic antigen (CEA) testing, computed tomography scanning, and endoscopic surveillance. Although CEA is the most widely used laboratory test, it has very low sensitivity (30–40%). Moreover, there is no evidence to support the association of CEA testing with improved survival or quality of life. Thus, novel markers with greater specificity and sensitivity are needed. The aim of this review was to define the role of available laboratory markers in early diagnosis of metastatic CRC. We identified novel tests with the highest association to metastatic CRC: circulating tumour DNA, growth/differentiation factor 15, and 6-integrin. We also discuss other promising markers, although most of the studies are preliminary and require validation.

keywords:

Markers of metastatic colorectal cancer

Piotr Myśliwiec 1 , Barbara Choromanska 1 , Jacek Dadan 1

colorectal cancer, metastasis, circulating tumour DNA

Piotr Myśliwiec

¹

,

Barbara Choromanska

¹

,

Jacek Dadan

¹